Chemoproteomics Reveals Berberine Directly Binds to PKM2 to Inhibit the Progression of Colorectal Cancer

The chemical proteomics method was used and demonstrated that berberine directly bound to pyruvate kinase isozyme type M2 (PKM2) in colorectal cancer cells.